{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:11:21Z","timestamp":1792267881778,"version":"4.4.0"},"reference-count":39,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Cancer"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Cancer survivorship is a complicated, chronic, and long-lasting experience, causing uncertainty and a wide range of physical and emotional health concerns. Due to the complexity of cancer, patients often seek out multiple sources of health information to better understand the aspects of their cancer diagnosis. The high variability among patients with cancer presents significant challenges in treatment, prognosis, and overall disease management. Artificial intelligence (AI) chatbots can further personalize cancer care delivery. However, there is a knowledge gap regarding cancer survivors\u2019 perceived facilitators and barriers to adopting and using AI chatbots.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n In this study, we examined cancer survivors\u2019 experiences of using existing AI chatbots and identified their facilitators and barriers to the adoption of AI chatbots.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We conducted a qualitative study to investigate the perceptions of cancer survivors, conducting semistructured interviews to understand their prior use of existing AI chatbots in general. We asked the participants about their perceptions regarding AI chatbot acceptability and comfort level; trust and adherence; and concerns, barriers, and suggestions. We used the Consolidated Criteria for Reporting Qualitative Research (COREQ) checklist for this qualitative report.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of 21 participants, 17 (81%) were female patients with breast cancer, 15 (71%) were aged 50 to 64 years, 19 (90%) were White, and 9 (43%) had a graduate degree. Participants\u2019 responses were grouped into three overarching themes: (1) patients\u2019 perceptions of interacting with chatbots compared to health care professionals, (2) patient-chatbot interaction, and (3) chatbot information processing. All participants who were interviewed reported that they would prefer interacting with health care professionals over a chatbot. The lack of empathy shown by chatbots was a major concern among cancer survivors. Many patients criticized chatbots for tending to provide a general overarching response to their questions rather than being specific to their cancer diagnosis. The main concerns of cancer survivors with using chatbots were the overabundance of general information that was often not relevant to their diagnosis and privacy of patient information.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The findings of this study underscore the critical importance of empathetic responses during AI chatbot interactions for cancer survivors, as the lack of personalized and emotional responses can lead to distrust and frustration. Clinically, these tools should be integrated as supplementary resources to enhance patient engagement while preserving essential human support. Policymakers need to develop guidelines that promote responsible use of AI in cancer care, prioritizing patient confidentiality and trustworthiness. AI chatbots have the potential to significantly improve the support provided to cancer survivors, but it is crucial to address the identified barriers and enhance user acceptance.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/77390","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T20:55:06Z","timestamp":1759697706000},"page":"e77390-e77390","source":"Crossref","is-referenced-by-count":13,"title":["Evaluation of Cancer Survivors\u2019 Experience of Using AI-Based Conversational Tools: Qualitative Study"],"prefix":"10.2196","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8992-2946","authenticated-orcid":false,"given":"Saif","family":"Khairat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5443-6777","authenticated-orcid":false,"given":"Hanna","family":"Mehraby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7343-1771","authenticated-orcid":false,"given":"Safoora","family":"Masoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9124-4601","authenticated-orcid":false,"given":"Melissa","family":"Coffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0601-4002","authenticated-orcid":false,"given":"Callie","family":"Rockey-Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8965-8579","authenticated-orcid":false,"given":"Andrea","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7439-2543","authenticated-orcid":false,"given":"William","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3813-9318","authenticated-orcid":false,"given":"Ethan","family":"Basch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"3","key":"R1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17030441","article-title":"Heterogeneity in cancer","volume":"17","author":"MacDonald","journal-title":"Cancers (Basel)"},{"key":"R2","unstructured":"Definition of survivorship. National Cancer Institute. Apr 2, 2025. URL: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/survivorship [Accessed 18-10-2025]"},{"issue":"1","key":"R3","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-022-00363-1","article-title":"Breast cancer heterogeneity and its implication in personalized precision therapy","volume":"12","author":"Guo","journal-title":"Exp Hematol Oncol"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Khatami F Patrinos GP Nikfar S et al. Personalized cancer therapies. In: Hasanzad M , editor. A Glimpse at Medicine in the Future. Springer; 2024:47-59. [doi: 10.1007\/978-981-97-4974-4_3]","DOI":"10.1007\/978-981-97-4974-4_3"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1017\/pcm.2024.1","article-title":"Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm","volume":"2","author":"Lajmi","journal-title":"Camb Prism Precis Med"},{"issue":"1","key":"R6","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11305-3","article-title":"Comparison of clinical outcomes among cancer patients treated in and out of clinical trials","volume":"23","author":"Duenas","journal-title":"BMC Cancer"},{"issue":"2","key":"R7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020242","article-title":"Personalized medicine: recent progress in cancer therapy","volume":"13","author":"Hoeben","journal-title":"Cancers (Basel)"},{"issue":"8","key":"R8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.24793","article-title":"Patient-reported outcome measures in cancer care: an updated systematic review and meta-analysis","volume":"7","author":"Balitsky","journal-title":"JAMA Netw Open"},{"issue":"1","key":"R9","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03734-w","article-title":"Intratumoral heterogeneity and drug resistance in cancer","volume":"25","author":"Fu","journal-title":"Cancer Cell Int"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.2196\/66633","article-title":"Developing effective frameworks for large language model-based medical chatbots: insights from radiotherapy education with ChatGPT","volume":"11","author":"Chow","journal-title":"JMIR Cancer"},{"issue":"4","key":"R11","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf038","article-title":"Medical accuracy of artificial intelligence chatbots in oncology: a scoping review","volume":"30","author":"Chen","journal-title":"Oncologist"},{"issue":"10","key":"R12","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1001\/jamaoncol.2023.2954","article-title":"Use of artificial intelligence chatbots for cancer treatment information","volume":"9","author":"Chen","journal-title":"JAMA Oncol"},{"issue":"7","key":"R13","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.3390\/curroncol31070284","article-title":"Quality of ChatGPT-generated therapy recommendations for breast cancer treatment in gynecology","volume":"31","author":"Stalp","journal-title":"Curr Oncol"},{"issue":"2","key":"R14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41391-024-00864-6","article-title":"ChatGPT can help guide and empower patients after prostate cancer diagnosis","volume":"28","author":"Collin","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.2196\/64406","article-title":"Ethical considerations in human-centered AI: advancing oncology chatbots through large language models","volume":"5","author":"Chow","journal-title":"JMIR Bioinform Biotechnol"},{"issue":"16_suppl","key":"R16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.e13607","article-title":"OncoGPT: Enhancing oncological decision-making with ASCO guideline\u2013trained AI","volume":"42","author":"El-Assal","journal-title":"JCO"},{"issue":"12","key":"R17","doi-asserted-by":"publisher","DOI":"10.2196\/39443","article-title":"Learning the treatment process in radiotherapy using an artificial intelligence-assisted chatbot: development study","volume":"6","author":"Rebelo","journal-title":"JMIR Form Res"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2024.108302","article-title":"Development of AI-generated medical responses using the ChatGPT for cancer patients","volume":"254","author":"Lee","journal-title":"Comput Methods Programs Biomed"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.2196\/72522","article-title":"Evaluating an AI chatbot \u201cProstate Cancer Info\u201d for providing quality prostate cancer screening information: cross-sectional study","volume":"11","author":"Owens","journal-title":"JMIR Cancer"},{"issue":"1","key":"R20","doi-asserted-by":"publisher","DOI":"10.63116\/VXUL2925","article-title":"The accuracy of ChatGPT in answering FAQs, making clinical recommendations, and categorizing patient symptoms: a literature review","volume":"1","author":"Geracitano","journal-title":"Adv Health Inf Sci Pract"},{"issue":"8","key":"R21","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14080877","article-title":"Chatbots in cancer applications, advantages and disadvantages: all that glitters is not gold","volume":"14","author":"Goumas","journal-title":"J Pers Med"},{"issue":"1","key":"R22","doi-asserted-by":"publisher","DOI":"10.1007\/s10916-024-02059-x","article-title":"Patient engagement with conversational agents in health applications 2016-2022: a systematic review and meta-analysis","volume":"48","author":"Cevasco","journal-title":"J Med Syst"},{"issue":"1","key":"R23","doi-asserted-by":"publisher","DOI":"10.1177\/1609406917733847","article-title":"Thematic analysis: striving to meet the trustworthiness criteria","volume":"16","author":"Nowell","journal-title":"Int J Qual Methods"},{"issue":"6","key":"R24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","journal-title":"Int J Qual Health Care"},{"key":"R25","unstructured":"All cancer sites combined recent trends in SEER age-adjusted incidence rates, 2000-2022. National Cancer Institute Surveillance, Epidemiology, and End Results Program. Sep 1, 2022. URL: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/application.html?site=1&data_type=1&graph_type=2&compareBy=sex&chk_sex_3=3&chk_sex_2=2&rate_type=2&race=1&age_range=1&hdn_stage=101&advopt_precision=1&advopt_show_ci=on&hdn_view=0&advopt_show_apc=on&advopt_display=2#resultsRegion0 [Accessed 17-10-2025]"},{"key":"R26","unstructured":"Definitions. National Cancer Institute Division of Cancer Control & Population Sciences. Mar 27, 2025. URL: https:\/\/cancercontrol.cancer.gov\/ocs\/definitions [Accessed 17-10-2025]"},{"issue":"1","key":"R27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How many interviews are enough?: an experiment with data saturation and variability","volume":"18","author":"Guest","journal-title":"Field Methods"},{"issue":"1","key":"R28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1089\/pmr.2020.0052","article-title":"Patients\u2019 and clinicians\u2019 perceptions of clinician-expressed empathy in advanced cancer consultations and associations with patient outcomes","volume":"1","author":"Hoffst\u00e4dt","journal-title":"Palliat Med Rep"},{"issue":"4","key":"R29","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/pon.6108","article-title":"The association of physician empathy with cancer patient outcomes: a meta-analysis","volume":"32","author":"Lelorain","journal-title":"Psychooncology"},{"issue":"12","key":"R30","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/pon.2115","article-title":"A systematic review of the associations between empathy measures and patient outcomes in cancer care","volume":"21","author":"Lelorain","journal-title":"Psychooncology"},{"issue":"22","key":"R31","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1002\/cncr.33834","article-title":"What is empathy? Oncology patient perspectives on empathic clinician behaviors","volume":"127","author":"Sanders","journal-title":"Cancer"},{"issue":"10","key":"R32","doi-asserted-by":"publisher","first-page":"664","DOI":"10.6004\/jnccn.2024.7055","article-title":"Empowering care teams: redefining message management to enhance care delivery and alleviate oncologist burnout","volume":"22","author":"Anderson","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"R33","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-023-02395-x","article-title":"Precision cancer medicine and the doctor-patient relationship: a systematic review and narrative synthesis","volume":"23","author":"Grauman","journal-title":"BMC Med Inform Decis Mak"},{"issue":"1","key":"R34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.pec.2013.09.016","article-title":"The cancer information overload (CIO) scale: establishing predictive and discriminant validity","volume":"94","author":"Jensen","journal-title":"Patient Educ Couns"},{"issue":"3","key":"R35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/bju.15662","article-title":"Application of artificial intelligence to overcome clinical information overload in urological cancer","volume":"130","author":"Stenzl","journal-title":"BJU Int"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1002\/hpja.387","article-title":"Health literacy, digital health literacy and the implementation of digital health technologies in cancer care: the need for a strategic approach","volume":"32 Suppl 1","author":"Kemp","journal-title":"Health Promot J Austr"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.2196\/74010","article-title":"Patient attitudes toward artificial intelligence in cancer care: scoping review","volume":"11","author":"Hilbers","journal-title":"JMIR Cancer"},{"issue":"1","key":"R38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.17294\/2330-0698.2029","article-title":"Patient perspectives on the use of artificial intelligence in health care: a scoping review","volume":"11","author":"Moy","journal-title":"J Patient Cent Res Rev"},{"issue":"9","key":"R39","doi-asserted-by":"publisher","first-page":"e599","DOI":"10.1016\/S2589-7500(21)00132-1","article-title":"Patient and general public attitudes towards clinical artificial intelligence: a mixed methods systematic review","volume":"3","author":"Young","journal-title":"Lancet Digit Health"}],"container-title":["JMIR Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cancer.jmir.org\/2025\/1\/e77390","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:09:33Z","timestamp":1782842973000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancer.jmir.org\/2025\/1\/e77390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":39,"URL":"https:\/\/doi.org\/10.2196\/77390","relation":{},"ISSN":["2369-1999"],"issn-type":[{"value":"2369-1999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"article-number":"v11i3e77390"}}